2 Things You Must Know About Xarelto Lawsuit

Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered critical bleeding events. Pharmaceutical firms, including the makers of Xarelto, have a duty to make sure that their drugs are reasonably safe for use - and failure to perform so might be grounds for compensation. Our lawyers are working challenging to obtain these hurt by the drug the compensation they are entitled to.

While bleeding is actually a typical complication connected with anticoagulants, it has been alleged that Xarelto is a lot more harmful than traditional blood thinners since no antidote exists to reverse its blood-thinning effects. This implies that, in the event of an emergency, patients might be at threat for irreversible bleeding issues, including life-threatening internal and gastrointestinal hemorrhaging.

Should you can find out more or possibly a loved one suffered a serious bleeding event right after taking Xarelto, you might have legal recourse. For far more details, get in touch with us right now to have your case reviewed, totally free of charge.
Compensation Possibilities

xarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for previous and future health-related bills, lost wages, pain and suffering and, in circumstances of death, funeral expenditures. Moreover, they're in search of punitive damages, that are typically awarded to punish the defendant and deter other organizations from acting similarly.
Why Are Lawsuits Getting Filed?

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is unsafe and defective. The plaintiffs claim that, unlike conventional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Since of this, the lawsuits claim, doctors have no effective indicates of stopping Xarelto users from bleeding inside the occasion of an emergency. Plaintiffs within the lawsuits allege critical and fatal injuries, like cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.

In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a secure anticoagulant option.
Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the event of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.
Xarelto is linked to severe bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.

Visit this page for more details on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set

The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.